These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9754599)

  • 21. Increased expression of constitutive nitric oxide synthase III, but not inducible nitric oxide synthase II, in human heart failure.
    Stein B; Eschenhagen T; Rüdiger J; Scholz H; Förstermann U; Gath I
    J Am Coll Cardiol; 1998 Nov; 32(5):1179-86. PubMed ID: 9809923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of nitric oxide in heart failure. Potential for pharmacological intervention.
    Macdonald P; Schyvens C; Winlaw D
    Drugs Aging; 1996 Jun; 8(6):452-8. PubMed ID: 8736629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endothelial dysfunction and heart failure.
    Ferrari R; Bachetti T
    Ital Heart J; 2001 Sep; 2 Suppl 3():45S-47S. PubMed ID: 11593933
    [No Abstract]   [Full Text] [Related]  

  • 24. Ischaemia or reperfusion: which is a main trigger for changes in nitric oxide mRNA synthases expression?
    Pevni D; Frolkis I; Shapira I; Schwartz D; Schwartz IF; Chernichovski T; Lev-Ran O; Sharony R; Uretzky G
    Eur J Clin Invest; 2005 Sep; 35(9):546-50. PubMed ID: 16128860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preservation of NO production by statins in the treatment of heart failure.
    Trochu JN; Mital S; Zhang Xp; Xu X; Ochoa M; Liao JK; Recchia FA; Hintze TH
    Cardiovasc Res; 2003 Nov; 60(2):250-8. PubMed ID: 14613854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nitroglycerin as a nitric oxide donor accelerates lipid peroxidation but preserves ventricular function in a canine model of orthotopic heart transplantation.
    Tanoue Y; Morita S; Ochiai Y; Haraguchi N; Tominaga R; Kawachi Y; Yasui H
    J Thorac Cardiovasc Surg; 1999 Sep; 118(3):547-56. PubMed ID: 10469974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heart failure, redox alterations, and endothelial dysfunction.
    López Farré A; Casado S
    Hypertension; 2001 Dec; 38(6):1400-5. PubMed ID: 11751725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secondary endothelial dysfunction: hypertension and heart failure.
    Boulanger CM
    J Mol Cell Cardiol; 1999 Jan; 31(1):39-49. PubMed ID: 10072714
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of Physiological Balance Between Nitric Oxide and Endothelium-Dependent Hyperpolarization Impairs Cardiovascular Homeostasis in Mice.
    Godo S; Sawada A; Saito H; Ikeda S; Enkhjargal B; Suzuki K; Tanaka S; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):97-107. PubMed ID: 26543099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelium-smooth muscle interaction in cardiac transplantation.
    Skarsgard PL; McManus BM; van Breemen C; Laher I
    Clin Exp Pharmacol Physiol; 1998 Oct; 25(10):836-40. PubMed ID: 9784926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of selective inhibitors of nitric oxide synthase-2 dimerization on acute cardiac allograft rejection.
    Szabolcs MJ; Sun J; Ma N; Albala A; Sciacca RR; Philips GB; Parkinson J; Edwards N; Cannon PJ
    Circulation; 2002 Oct; 106(18):2392-6. PubMed ID: 12403672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does endothelium-derived nitric oxide have a role in cytokine-induced hypotension?
    Nathan CF; Stuehr DJ
    J Natl Cancer Inst; 1990 May; 82(9):726-8. PubMed ID: 1691302
    [No Abstract]   [Full Text] [Related]  

  • 33. Does third generation left ventricular assist device alter heart failure-related microvascular dysfunction?
    Esmaeilzadeh F; Dendievel R; Wauters A; Vachiery JL; Van Nooten G; Van De Borne P; Argacha JF
    Acta Cardiol; 2016 Aug; 71(4):403-10. PubMed ID: 27594355
    [No Abstract]   [Full Text] [Related]  

  • 34. Does ADMA cause endothelial dysfunction?
    Cooke JP
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2032-7. PubMed ID: 10978245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of inducible nitric oxide synthase and superoxide production reduces matrix metalloproteinase-9 activity and restores coronary vasomotor function in rat cardiac allografts.
    Egi K; Conrad NE; Kwan J; Schulze C; Schulz R; Wildhirt SM
    Eur J Cardiothorac Surg; 2004 Aug; 26(2):262-9. PubMed ID: 15296881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nitric oxide in septic shock.
    Titheradge MA
    Biochim Biophys Acta; 1999 May; 1411(2-3):437-55. PubMed ID: 10320674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitric oxide in the failing myocardium.
    Sawyer DB; Colucci WS
    Cardiol Clin; 1998 Nov; 16(4):657-64, viii. PubMed ID: 9891595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endothelial dysfunction in heart failure: mechanisms and therapeutic approaches.
    Bauersachs J; Schäfer A
    Curr Vasc Pharmacol; 2004 Apr; 2(2):115-24. PubMed ID: 15320512
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endothelial dysfunction: a global response].
    López-Farré A; Farré J; Sánchez de Miguel L; Romero J; González-Fernández F; Casado S
    Rev Esp Cardiol; 1998; 51 Suppl 6():18-22. PubMed ID: 10050140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine-induced nitric oxide inhibits mitochondrial energy production and induces myocardial dysfunction in endotoxin-treated rat hearts.
    Tatsumi T; Akashi K; Keira N; Matoba S; Mano A; Shiraishi J; Yamanaka S; Kobara M; Hibino N; Hosokawa S; Asayama J; Fushiki S; Fliss H; Nakagawa M; Matsubara H
    J Mol Cell Cardiol; 2004 Sep; 37(3):775-84. PubMed ID: 15350850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.